5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.46%
Positive revenue growth while HUH1V.HE is negative. John Neff might see a notable competitive edge here.
-41.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
14800.00%
Positive EBIT growth while HUH1V.HE is negative. John Neff might see a substantial edge in operational management.
14800.00%
Positive operating income growth while HUH1V.HE is negative. John Neff might view this as a competitive edge in operations.
445.83%
Positive net income growth while HUH1V.HE is negative. John Neff might see a big relative performance advantage.
444.12%
Positive EPS growth while HUH1V.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
444.12%
Positive diluted EPS growth while HUH1V.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.13%
Share reduction while HUH1V.HE is at 0.03%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.13%
Reduced diluted shares while HUH1V.HE is at 0.03%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-106.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-150.08%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-0.63%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 76.09%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-1.75%
Negative 5Y CAGR while HUH1V.HE stands at 24.88%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-1.70%
Negative 3Y CAGR while HUH1V.HE stands at 24.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
57.19%
10Y OCF/share CAGR under 50% of HUH1V.HE's 500.71%. Michael Burry would worry about a persistent underperformance in cash creation.
-121.47%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 227.85%. Joel Greenblatt would question the firm’s operational model or cost structure.
-147.18%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 59.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-45.61%
Negative 10Y net income/share CAGR while HUH1V.HE is at 29.57%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-78.25%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-79.10%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
109.02%
10Y equity/share CAGR at 75-90% of HUH1V.HE's 134.63%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
36.19%
5Y equity/share CAGR at 75-90% of HUH1V.HE's 48.01%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
20.75%
3Y equity/share CAGR at 50-75% of HUH1V.HE's 38.89%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.70%
AR growth well above HUH1V.HE's 7.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.16%
Inventory growth well above HUH1V.HE's 6.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.21%
Negative asset growth while HUH1V.HE invests at 2.20%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.35%
We have a declining book value while HUH1V.HE shows 3.88%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.78%
We have some new debt while HUH1V.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.